InvestorsHub Logo

Phosphene

10/26/22 2:01 PM

#22 RE: DewDiligence #21

Will this impact Grant's $1.79 options or the 10,000 + company shares he sells at market price monthly?

DewDiligence

11/07/22 7:05 PM

#25 RE: DewDiligence #21

PCVX has around $1B(!) in cash:

https://www.globenewswire.com/news-release/2022/11/07/2550261/0/en/Vaxcyte-Reports-Third-Quarter-2022-Financial-Results-and-Provides-Business-Update.html

-- $366.2 Million in Cash, Cash Equivalents and Investments as of September 30, 2022, Excluding Net Proceeds of Approximately $650.7 Million from Recent Public Offering –